Global Colorectal Cancer Drugs Market Size, Industry Trends, Share and Forecast 2019– 2025


Posted September 10, 2020 by Larebomrglobal123

Colorectal Cancer Drugs Market Size, Share & Trends Analysis Report by Drug Class Type and Forecast 2019-2025
 
The global colorectal cancer drugs market is estimated to grow at a CAGR of 5.0% during the forecast period. Increasing prevalence of colorectal cancer globally, improving healthcare infrastructure across emerging economies, rising health awareness, and growing focus of market players towards the development of cancer drugs and other therapeutic solutions are some of the driving factors for the market growth. Furthermore, rising geriatric population, the increasing advancement of cancer screening tests, and increasing awareness among the population regarding the prevalence of cancer are some of the factors that are contributing towards the growth of the global colorectal cancer drugs market.

A full Report of Global Colorectal Cancer Drugs Market is Available at: https://www.omrglobal.com/industry-reports/colorectal-cancer-drugs-market

Increasing colorectal cancer prevalence is driving the global market

Increasing prevalence and incidence of these types of cancers are fueling the segmental growth of the market. According to the American Cancer Society, colorectal cancer is diagnosed in more than 1.2 million people globally every year, with North America being the most dominant region. Moreover, the World Health Organization (WHO) has stated that the incidence of colorectal cancer is around 93,898 in men and 85,873 in women; whereas, it has caused mortalities to nearly 33,752 men and 30,369 women during 2018. The increasing prevalence of cancers addresses the need for right treatment solutions including drugs; thereby, drives the global colorectal cancer drugs market.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/colorectal-cancer-drugs-market

Global Colorectal Cancer Drugs Market Segmentation

By Drug Class Type

• Chemotherapy
• Targeted Therapy
• Immunotherapy
• Hormonal Therapy

Regional Analysis

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

Company Profiles

• AbbVie Inc.
• Amgen Inc.
• AstraZeneca PLC
• Bayer AG
• Bristol-Myers Squibb Co.
• Celgene Corp.
• Eli Lilly and Co.
• F. Hoffmann-La Roche Ltd.
• Merck & Co., Inc.,
• Novartis AG
• Pfizer Inc.
• Sanofi SA

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/colorectal-cancer-drugs-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com
Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. AnuragTiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 780-304-0404
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Lareb Khan
Phone 07803040404
Business Address 305, Commerce House, 308, 11 Bungalow Colony, New Palasia, Indore, Madhya Pradesh
Country India
Categories Health , Medical , News
Tags colorectal cancer drugs market , colorectal cancer drugs market analysis , colorectal cancer drugs market forecast , colorectal cancer drugs market growth , colorectal cancer drugs market share , healthcare , pharmaceuticals
Last Updated September 10, 2020